HealthCare Royalty Partners (“HCR”) is a private investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage biopharmaceutical assets. They target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to their marketer. They also look for assets that will produce sustainable revenues over an extended period of time. Their investments span the pharmaceutical, biotechnology, and specialty pharmaceuticals sectors.

Investment Management

HealthCare Royalty Partners

HealthCare Royalty Partners' headquarters in Stamford, CT, United States

Clarke B. Futch

Joshua C. House

Tolly Flinn

Collin G. Stewart

Timothy R.M. Bryant

Christopher A. White

Lauren C. Jorgensen

John A. Urquhart

Shin W. Kang

Warren D. Cooper

Carlos M. Almodóvar

Anthony G. Rapsomanikis

Michele D. Romaniello

Thomas K. Conner

Michael G. Carter

Frank M. Armstrong

Natale S. Ricciardi

Gregory B. Brown

William M. Burns

Robert S. Langer

Gary A. Lyons

Julie H. McHugh

Description

People (4)

Rosa I. Mercado

Hayden C.B. Futch

Tolly Flinn

Aaron B. Simon

Jobs